Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.
about
Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH)Atypical hemolytic uremic syndromeCurrent treatment of atypical hemolytic uremic syndromeThree new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancyAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.The MMACHC proteome: hallmarks of functional cobalamin deficiency in humans.Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.The Genetics of Ultra-Rare Renal Disease.Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.Treatment of cobalamin C (cblC) deficiency during pregnancy.Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Factors influencing treatment of atypical hemolytic uremic syndrome.A child presenting with severe hypertension and circulatory failure-a diagnostic conundrum: Answers.
P2860
Q21134757-70E7C47A-84FE-4904-B062-759524BB167AQ21202864-C36EE869-2DD4-40DD-9B89-46212343BF56Q27003211-12EC27BB-C35D-4729-858C-C16BC07ADD9EQ27013643-10B4F93D-1346-4A95-BC82-41A048FA3123Q33421861-62484DC7-4433-49DB-B9CB-C0A78F0070F0Q33422024-CFAED1FD-8FA2-4AE6-9E26-57B9D2F879C2Q34038698-94A792D7-5034-4E6A-AFCF-22D19BE81889Q34448257-CF312466-68E1-4625-A54B-5AD270A55F97Q35032688-A65A505C-EDE7-4CBB-8C51-299E5EFB2DA3Q36485435-B5520475-8130-46C0-83CC-508B82324801Q37032691-2CEEF54C-5857-412F-A0A8-D2D7D16C705AQ37547491-1A14E549-57FD-41E2-8C80-DADB7792F8A7Q37787093-E24F76C7-5DF1-46C7-B7EA-15EE26081CEAQ38027777-61086D89-EFD1-4C72-B424-6563DC7D2018Q38862309-BB2D10B0-8A35-4AA5-9F73-149302663733Q40715358-89FEA476-6B15-4A37-9FFD-7D8ABD1FD4D4Q42086661-AAD44CF9-7C92-4036-89F9-510F46FFEEC6Q42858176-31FEB8C9-59C8-4374-A2E9-DBFA09F199E9Q49118448-A8C0FFDF-45E8-481A-B349-C97E40B973F0
P2860
Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Late-onset thrombocytic microa ...... tion with a factor H mutation.
@ast
Late-onset thrombocytic microa ...... tion with a factor H mutation.
@en
type
label
Late-onset thrombocytic microa ...... tion with a factor H mutation.
@ast
Late-onset thrombocytic microa ...... tion with a factor H mutation.
@en
prefLabel
Late-onset thrombocytic microa ...... tion with a factor H mutation.
@ast
Late-onset thrombocytic microa ...... tion with a factor H mutation.
@en
P2093
P50
P1476
Late-onset thrombocytic microa ...... tion with a factor H mutation.
@en
P2093
Béatrice Mougenot
David S Rosenblatt
Didier Borderie
Georges Deschênes
Rémi Favier
Stéphane Giraudier
Véronique Frémeaux-Bacchi
Ziad Massy
P304
P356
10.1053/J.AJKD.2004.12.004
P577
2005-03-01T00:00:00Z